sepsis lecture 2015 slide share
TRANSCRIPT
![Page 1: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/1.jpg)
Sepsis / Septic Shockfor 3rd year MBBS
Dr. Ahmad Uzair QureshiFCPS ( SURGERY) / MCPS ( SURGERY)
MRCS ( ENGLAND) / Dip Med Edu (Cardiff) Colorectal Fellow Yonsei University, South Korea
Assistant Professor of Surgery, King Edward Medical University, Lahore
![Page 2: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/2.jpg)
![Page 3: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/3.jpg)
![Page 4: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/4.jpg)
SEPSIS“Is a systemic, harmful ( deleterious) host response to infection”.
![Page 5: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/5.jpg)
SEPSIS“Is a systemic, deleterious host response to infection”.
leading to
![Page 6: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/6.jpg)
Severe Sepsis (acute organ dysfunction secondary to documented or suspected infection)
![Page 7: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/7.jpg)
Severe Sepsis (acute organ dysfunction secondary to documented or suspected infection)
leading to
Dysfunction of organ(s) distant from the site of infection
![Page 8: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/8.jpg)
SEPTIC SHOCK (severe sepsis plus hypoperfusion or hypotension not reversed
with fluid resuscitation).”
![Page 9: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/9.jpg)
INFECTION
![Page 10: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/10.jpg)
INFECTIONPresence of microorganisms in a normally sterile site
![Page 11: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/11.jpg)
INFECTIONPresence of microorganisms in a normally sterile site
Do Not confuse with “colonization,” which is the presence of microorganisms on an epithelial surface
![Page 12: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/12.jpg)
Bacteremia
![Page 13: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/13.jpg)
BacteremiaCultivatable bacteria in the bloodstream
May be transient and inconsequential;
![Page 14: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/14.jpg)
Systemic inflammatory response syndrome
(SIRS)
![Page 15: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/15.jpg)
Systemic inflammatory response syndrome
(SIRS)
Discarded2012
![Page 16: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/16.jpg)
Early Host Responses to Infection Local Defenses: Walling Off and Killing Invading Microbes
![Page 17: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/17.jpg)
Early Systemic Responses: Keeping Infection and Inflammation Localized
![Page 18: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/18.jpg)
Acute-Phase Responses (Categorized According to Possible Roles in Defense)
Anti-infective Increases synthesis of complement factors, microbe pattern-recognition molecules (mannose-binding lectin, LBP, CRP, CD14, others) Sequesters iron (lactoferrin, hepcidin) and zinc (metallothionein)
Anti-inflammatory Releases anti-inflammatory neuroendocrine hormones (cortisol, ACTH, epinephrine, α-MSH) Increases synthesis of proteins that help prevent inflammation within the systemic compartment Cytokine antagonists (IL-1Ra, sTNF-Rs) Anti-inflammatory mediators (e.g., IL-4, IL-6, IL-6R, IL-10, IL-13, TGF-β) Protease inhibitors (e.g., α1-antiprotease) Antioxidants (haptoglobin) Reprograms circulating leukocytes (epinephrine, cortisol, PGE 2 , ? other factors)
Procoagulant Walls off infection, prevents systemic spread Increases synthesis or release of fibrinogen, PAI-1, C4b Decreases synthesis of protein C, antithrombin III
Metabolic Preserves euglycemia, mobilizes fatty acids, amino acids Epinephrine, cortisol, glucagon, cytokines
Thermoregulatory Inhibits microbial growth Fever
Early Systemic Responses: Keeping Infection and Inflammation Localized
![Page 19: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/19.jpg)
Harmful Responses to Infection: Severe Sepsis and Septic Shock
Develop when normally adaptive stress responses are pushed beyond their ability to be protective.
“Hypofunction” implies an inadequate level of activity, whereas “dysfunction” suggests that organ performance is in some way abnormal.
![Page 20: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/20.jpg)
CONCEPTs 1.Microvascular derangement 2.Mitochondrial dysfunction. TWO Theories
![Page 21: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/21.jpg)
• An extension of the body's normal neuroendocrine responses to stress
• An exhaustion of ATP in critical organs • when the inflammatory stimulus is too strong or too prolonged.
![Page 22: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/22.jpg)
• Cytokines circulate via the blood and induce injury to the vascular endothelium and/or microcirculation in different organs.
• An extension of the body's normal neuroendocrine responses to stress
• An exhaustion of ATP in critical organs • when the inflammatory stimulus is too strong or too prolonged.
![Page 23: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/23.jpg)
Septic ShockOpportunistic commensal bacteria typically invade across disrupted epithelia.
Hosts in whom immunosuppressive acute-phase responses are already occurring because of illness, injury, or infection.
Host is unable to kill the bacteria because of mechanical failure (obstructed drainage pathway), immunosuppression (neutropenia, “endogenous immunosuppression”)
![Page 24: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/24.jpg)
• These bacteria invade the bloodstream when local defenses are unable to kill or contain them; bacteremia.
• Locally-produced mediators act as trigger for severe sepsis and septic shock
• Outcome is strongly related to the patient's underlying physiologic fitness.
![Page 25: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/25.jpg)
![Page 26: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/26.jpg)
• Pathogenic microbes/virus that can survive and multiply in previously healthy humans.
• the microbes/viruses may enter the bloodstream, infect vascular endothelial cells and/or blood cells, and release toxins.
• The circulating microbes may provoke both shock and profound coagulopathy that not uncommonly results in hemorrhage and/or arterial thrombosis
![Page 27: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/27.jpg)
DIAGNOSTIC CRITERIA
![Page 28: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/28.jpg)
![Page 29: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/29.jpg)
![Page 30: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/30.jpg)
![Page 31: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/31.jpg)
Initial Resuscitation and Infection IssuesA. Initial Resuscitation (Goals during the first 6 hrs of resuscitation)1. Hypotension persisting after initial fluid challenge or blood lactate
concentration ≥ 4 mmol/La) Central venous pressure 8–12 mm Hg
b) Mean arterial pressure (MAP) ≥ 65 mm Hg
c) Urine output ≥ 0.5 mL/kg/hr
d) Central venous (superior vena cava) or mixed venous oxygen saturation 70% or 65%, respectively
![Page 32: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/32.jpg)
B. Diagnosis
• Cultures as clinically appropriate before antimicrobial therapy if no
significant delay (> 45 mins) in the start of antimicrobial(s)
• At least 2 sets of blood cultures (both aerobic and anaerobic bottles) be
obtained before antimicrobial therapy
• Imaging studies performed promptly to confirm a potential source of
infection (UG).
![Page 33: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/33.jpg)
C. Antimicrobial Therapy• Administration of effective intravenous antimicrobials within the first hour
of recognition of septic shock and severe• sepsis without septic shock as the goal of therapy.• Initial empiric anti-infective therapy of one or more drugs that have
activity against all likely pathogens • Antimicrobial regimen should be reassessed daily for potential
deescalation.• Use of low procalcitonin levels in the discontinuation of empiric antibiotics • Combination empirical therapy for neutropenic respiratory failure and
septic shock,
![Page 34: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/34.jpg)
TO BE COMPLETED WITHIN 3 HOURS OF TIME OF PRESENTATION*:
1. Measure lactate level
2. Obtain blood cultures prior to administration of antibiotics
3. Administer broad spectrum antibiotics
4. Administer 30ml/kg crystalloid for hypotension or lactate ≥4mmol/L
![Page 35: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/35.jpg)
TO BE COMPLETED WITHIN 6 HOURS OF TIME OF PRESENTATION:
5. Apply vasopressors (for hypotension that does not respond to initial fluid resuscitation) to maintain a mean arterial pressure (MAP) ≥65mmHg
6. In the event of persistent hypotension after initial fluid administration (MAP < 65 mm Hg) or if initial lactate was ≥4 mmol/L, re-assess volume status and tissue perfusion 7. Re-measure lactate if initial lactate elevated.
![Page 36: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/36.jpg)
Fluid Therapy of Severe Sepsis
• Crystalloids as the initial fluid of choice • Against the use of hydroxyethyl starches • Albumin when substantial amounts of crystalloids (grade 2C).• Initial fluid challenge a minimum of 30 mL/kg of crystalloids (a portion of this may be albumin equivalent). • Fluid challenge technique be applied
Change in pulse pressure,Stroke volume variation) Arterial pressure, Heart rate
![Page 37: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/37.jpg)
Vasopressors• Vasopressor therapy initially to target a mean arterial pressure (MAP) of 65 mm Hg
• Norepinephrine as the first choice vasopressor.
• Epinephrine (added to and potentially substituted for norepinephrine) when an additional agent is needed to maintain adequate blood pressure (grade 2B).
• Vasopressin 0.03 units/minute can be added to norepinephrine (NE) with intent of either raising MAP or decreasing NE dosage .
• Low dose vasopressin is not recommended as the single initial vasopressor for treatment of sepsis-induced hypotension and vasopressin doses higher than 0.03-0.04 units/minute should be reserved for salvage therapy (failure to achieve adequate MAP with other vasopressor agents) .
• Dopamine as an alternative vasopressor agent to norepinephrine only in highly selected patients (eg. patients with low risk of tachyarrhythmias and absolute or relative bradycardia).
![Page 38: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/38.jpg)
Hemodynamic Support and Adjunctive Therapy
• Inotropic Therapy• Corticosteroids• Blood Product Administration.• Immunoglobulins• Mechanical Ventilation of Sepsis-Induced ARDS• Sedation, Analgesia, and Neuromuscular Blockade in Sepsis• Glucose Control• Renal Replacement Therapy• Bicarbonate Therapy• Deep Vein ThrombosisProphylaxis• Nutrition
![Page 39: Sepsis lecture 2015 slide share](https://reader034.vdocument.in/reader034/viewer/2022051709/587084391a28ab57368b72bd/html5/thumbnails/39.jpg)
For any queries [email protected]